Connect your AI

Omeros OMER Finance Lease Liabilities

Discontinued — last reported Q4 '25

Finance Lease Liabilities at other companies

Kymera TherapeuticsKYMR

$1.15M-39.7%

Alumis Inc.ALMS

$0—

Opko HealthOPK

$3.01M-20.9%

Other financials

Income statement

Revenue$9.9M—

Gross profit$29.7M—

Operating income-$40.9M-9.2%

Net income$56.1M+268%

EPS (diluted)-$0.59-20.4%

Balance sheet

Cash & equivalents$1.9M-55.3%

Total debt$13.5M-30.3%

Total equity-$63.3M+70.3%

Total assets$286.2M+21.7%

Cash flow

Operating cash flow-$14.5M+59.5%

CapEx--100%

Free cash flow-$14.5M+59.6%

Valuation

Market cap$775.86M+313%

P/S8.6×—

Profitability

Gross margin98.9%—

Operating margin-181.8%—

Net margin-136.6%—

FCF margin-121.6%—

Returns & leverage

Return on equity86.6%—

Debt / equity0.3×-1.1×

Current ratio3×+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.

The official record: Omeros’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omeros's finance lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Omeros's finance lease liabilities?: Omeros (OMER) reported finance lease liabilities of $721K in Q4 2025.
How has Omeros's finance lease liabilities changed year-over-year?: Omeros's finance lease liabilities decreased by 41.9% year-over-year, from $1.24M to $721K.
What is the long-term trend for Omeros's finance lease liabilities?: Over 5 years (2020 to 2025), Omeros's finance lease liabilities has grown at a -0.5% compound annual growth rate (CAGR), from $738K to $721K.
What does finance lease liabilities mean?: Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.